Obesity indication approval expanded GLP-1 addressable market by an estimated 10-15: The US obesity drug market was approximately USD 2 billion in 2021 before Wegovy's approval
Top Key Players and Market Share Insights: The L-Carnitine market is highly competitive with major players providing precise products to the national and international markets
Vu HL, Rosenbaum S, Capparelli C, Purwin TJ, Davies MA , Berger AC, Aplin AE
Ongoing Follow-Up and Support We follow your progress over time and adjust your treatment plan based on your results, symptoms, and goals through our online weight loss program
They may recommend a temporary dose pause, slower escalation, or a switch to oral semaglutide (which some patients tolerate better)
Risks include inappropriate dosing, missed drug interactions, failure to recognize serious side effects, and use of contaminated or mislabeled products